Professor Juan Marchal

Propanc Biopharma’s Joint Research Partnership with the Universities of Jaén and Granada Enters 13th Year

Retrieved on: 
Wednesday, February 23, 2022
Biotechnology, FDA, Health, Pharmaceutical, Oncology, Research, Hospitals, Surgery, Genetics, Science, Clinical Trials, the University of Jaén, the University of Granada, Professor Macarena Perán, Professor Juan Marchal, Propanc Biopharma, Inc., THE UNIVERSITY OF JAéN, THE UNIVERSITY OF GRANADA, PROFESSOR MACARENA PERáN, PROFESSOR JUAN MARCHAL, PROPANC BIOPHARMA, INC.

The joint research partnership with the Universities of Jan and Granada has been critical for the advancement of our drug development program at Propanc Biopharma, said Dr. Julian Kenyon.

Key Points: 
  • The joint research partnership with the Universities of Jan and Granada has been critical for the advancement of our drug development program at Propanc Biopharma, said Dr. Julian Kenyon.
  • Furthermore, since international borders appear to have reopened, Dr Kenyon and I plan to visit the joint research team at Granada, Spain, June, 2022.
  • The POP1 joint research and drug discovery program is designed to produce a backup clinical compound to the Companys lead product candidate, PRP.
  • Propanc is undertaking the challenging research project with the Universities of Jan and Granada.

Professor Juan Marchal Believes Propanc Biopharma’s Proenzyme Therapy May Offer New Treatment Opportunity for Cancer Patients

Retrieved on: 
Monday, February 15, 2021
Research, Pharmaceutical, Oncology, Hospitals, Genetics, Clinical trials, Science, Surgery, Biotechnology, FDA, Other Science, Health, Cancer, Treatment of cancer, Causes of death, Prostate cancer, Health, Gastrointestinal cancer, Infectious causes of cancer, Neoplasms, Professor Juan Marchal, Propanc Biopharma, Inc.

This is particularly significant, since the incidence of metastasis greatly reduces the life expectancy of cancer patients.

Key Points: 
  • This is particularly significant, since the incidence of metastasis greatly reduces the life expectancy of cancer patients.
  • Searching for new cancer treatments to achieve a definitive cure for cancer patients is my motivation.
  • I am very excited to see what our therapy can do for cancer patients in future clinical studies.
  • Prof Juan Antonio Marchal, M.D, Ph.D., is a Professor of Human Anatomy and Embryology (Faculty of Medicine) at the University of Granada.